Skip to Content

TEVA 5045 (Dexmethylphenidate Hydrochloride Extended-Release 25 mg)

Pill with imprint TEVA 5045 is Blue & White, Capsule-shape and has been identified as Dexmethylphenidate Hydrochloride Extended-Release 25 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Dexmethylphenidate is used in the treatment of adhd; auditory processing disorder and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dexmethylphenidate 25 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 5045

Dexmethylphenidate hydrochloride extended-release 25 mg TEVA 5045

Dexmethylphenidate Hydrochloride Extended-Release

Imprint:
TEVA 5045
Strength:
25 mg
Color:
Blue & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Labeler / Supplier:
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC):
00093-5045

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide